MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹477 Cr | ₹390 Cr | ₹341 Cr | ₹380 Cr | ₹299 Cr |
What is the latest Total Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹477 Cr |
| Mar2024 | ₹390 Cr |
| Mar2023 | ₹341 Cr |
| Mar2022 | ₹380 Cr |
| Mar2021 | ₹299 Cr |
How is Total Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹477 Cr | 22.44 | |
| Mar2024 | ₹390 Cr | 14.33 | |
| Mar2023 | ₹341 Cr | -10.29 | |
| Mar2022 | ₹380 Cr | 27.13 | |
| Mar2021 | ₹299 Cr | - | |
Compare Total Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,378.1 Cr | -4.1% | -6.5% | -24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -4.1% |
-6.5% |
-24% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses